Independent Research set a €38.50 ($44.77) price target on Siemens Healthineers (ETR:SHL) in a report issued on Monday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
A number of other analysts have also recently issued reports on the company. Royal Bank of Canada set a €36.00 ($41.86) target price on Siemens Healthineers and gave the stock a neutral rating in a report on Thursday, May 2nd. DZ Bank reiterated a buy rating on shares of Siemens Healthineers in a report on Friday, May 3rd. JPMorgan Chase & Co. set a €34.00 ($39.53) target price on Siemens Healthineers and gave the stock a neutral rating in a report on Thursday, May 2nd. Jefferies Financial Group set a €38.00 ($44.19) target price on Siemens Healthineers and gave the stock a neutral rating in a report on Friday, May 3rd. Finally, Goldman Sachs Group set a €34.50 ($40.12) target price on Siemens Healthineers and gave the stock a neutral rating in a report on Thursday, May 2nd. Thirteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock has a consensus rating of Hold and a consensus target price of €38.15 ($44.36).
SHL opened at €37.17 ($43.22) on Monday. The company has a debt-to-equity ratio of 46.72, a current ratio of 1.44 and a quick ratio of 0.97. The stock has a market capitalization of $37.15 billion and a price-to-earnings ratio of 28.81. Siemens Healthineers has a 12 month low of €31.90 ($37.09) and a 12 month high of €39.95 ($46.45).
About Siemens Healthineers
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
See Also: Gross Domestic Product (GDP)
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.